Article Versions Notes

Batchu RB, Gruzdyn OV, Bryant CS, Qazi AM, Kumar S, Chamala S, Kung ST, Sanka RS, Puttagunta US, Weaver DW, et al. Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. Pharmaceuticals. 2014; 7(1):46-57. https://doi.org/10.3390/ph7010046

Batchu, Ramesh B., Oksana V. Gruzdyn, Christopher S. Bryant, Aamer M. Qazi, Sanjeev Kumar, Sreedhar Chamala, Shu T. Kung, Ramana S. Sanka, Udaya S. Puttagunta, Donald W. Weaver, and et al. 2014. "Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways" Pharmaceuticals 7, no. 1: 46-57. https://doi.org/10.3390/ph7010046

Batchu, R. B., Gruzdyn, O. V., Bryant, C. S., Qazi, A. M., Kumar, S., Chamala, S., Kung, S. T., Sanka, R. S., Puttagunta, U. S., Weaver, D. W., & Gruber, S. A. (2014). Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. Pharmaceuticals, 7(1), 46-57. https://doi.org/10.3390/ph7010046